03 August 2021: Clinical Research
Effect of Dexmedetomidine on Perioperative Hemodynamics and Myocardial Protection in Thoracoscopic-Assisted Thoracic Surgery
Hua Li ACE* , Ji Liu BD* , Hong Shi AG*DOI: 10.12659/MSM.929949
Med Sci Monit 2021; 27:e929949
Table 2 Intraoperative hemodynamic results and the duration of hospital stay.
| Variables | Dexmedetomidine group (n=88) | Control group (n=87) | P value | |
|---|---|---|---|---|
| Intraoperative hypotension | No | 63 | 43 | 0.011 |
| Yes | 25 | 41 | ||
| Intraoperative hypertension | No | 77 | 60 | 0.003 |
| Yes | 11 | 27 | ||
| Heart rate >110 beats/min | No | 87 | 79 | 0.016 |
| Yes | 1 | 8 | ||
| Dopamine | (mg) | 0.34±0.97 | 1.70±2.10 | |
| Nicardipine | (mg) | 0.24±0.83 | 0.70±1.50 | 0.013 |
| Atropine | (mg) | 0.25±0.33 | 0.06±0.18 | |
| Esmolol | (mg) | 0.23±2.13 | 2.99±9.90 | 0.013 |
| Hospital stay | (days) | 5.00±1.27 | 5.57±1.44 | 0.006 |
| P | ||||